L-arginine third party tested
Selected indexed studies
- Effects of treatment with SGLT-2 inhibitors on arginine-related cardiovascular and renal biomarkers. (Cardiovasc Diabetol, 2022) [PMID:34991562]
- Health care resource utilization in the management of patients with Arginase 1 Deficiency in the US: a retrospective, observational, claims database study. (J Med Econ, 2022) [PMID:35695271]
- The Influence of Beta-2 Adrenergic Receptor Gene Polymorphisms on Albuterol Therapy for Patients With Asthma: Protocol for a Systematic Review and Meta-Analysis. (JMIR Res Protoc, 2019) [PMID:31538939]
_Worker-drafted node — pending editorial review._
Connections
L-arginine third party tested protects against
L-arginine third party tested helps
Sources
- Effects of treatment with SGLT-2 inhibitors on arginine-related cardiovascular and renal biomarkers. (2022) pubmed
- Health care resource utilization in the management of patients with Arginase 1 Deficiency in the US: a retrospective, observational, claims database study. (2022) pubmed
- The Influence of Beta-2 Adrenergic Receptor Gene Polymorphisms on Albuterol Therapy for Patients With Asthma: Protocol for a Systematic Review and Meta-Analysis. (2019) pubmed
- Characterization of the immunosuppressive effects of nitric oxide in graft vs host disease. (1993) pubmed